Company intelligence / Profile preview

GAEA Biotech

Ownership: Private
Development stage: Commercial

Overview

Gaea is a full-service CRO conducting clinical trials across Europe, UK, Ukraine, USA, with additional partnerships in Bangladesh and West Africa. They specialize in trial enrollment acceleration and have expertise in acute-care, oncology, and hematology.

Therapeutic areas: PulmonologyOncologyHematology
Modalities: Investigational Medicinal Products (IMP)Medical Devices
Industry: Contract Research Organization

Partnerships

Partners in Bangladesh (for infectious diseases including COVID-19 vaccine trials)Partners in West Africa

Beyond the preview

Go deeper on GAEA Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GAEA Biotech.

Explore the full profile